Antimicrobial, Quorum Sensing Inhibition, and Anti-Cancer Activities of Silver Nanoparticles Synthesized from Kenyan Bacterial Endophytes of .

Untapped bioactive compounds from microbial endophytes offer a promising solution to counter antimicrobial and chemotherapeutic drug resistance when complexed as silver nanoparticles (AgNPs). AgNPs were biosynthesized using cell-free supernatants from endophytic sp. KE4D and KE4K isolated from the Kenyan medicinal plant , following fermentation in three different media. Bacterial extracts were analyzed using gas chromatography-mass spectrometry. AgNPs were characterized using Fourier-transform infrared spectroscopy and high-resolution transmission electron microscopy. Antimicrobial activity was assessed using agar well diffusion assays, and quorum sensing inhibition (QSI) was investigated using . Anti-cancer potential was evaluated against breast (MCF-7) and prostate cancer (DU-145) cell lines using MTT assays. AgNPs were 5-55 nm in size, with KE4D AgNPs being spherical and KE4K AgNPs exhibiting various shapes. Cyclopropane acetic acids and fatty acids were identified as possible capping agents. Medium-dependent antimicrobial activity was observed, with medium Mannitol and medium 5294 AgNPs displaying stronger activity, particularly against Gram-negative indicators. KE4D medium 5294 AgNPs demonstrated 85.12% violacein inhibition at 140 µg/mL and better QSI activity, whilst KE4K AgNPs were better antimicrobials. The AgNPs IC values were <3.5 µg/mL for MCF-7 and <2.5 µg/mL for DU-145 cells. The bioactivity of biosynthesized AgNPs is influenced by the bacterial isolate and fermentation medium, suggesting that AgNP synthesis can be tailored for specific bioactivity.